045sek
1,8 %
Date:2025-05-13Time:18:00:00Latest report:Q1-2025List:First NorthTicker:TOL
Market Cap:121 msekEnterprise Value:116 msekNet Sales:- msekEarnings:-11,9 msekEmployees:0ISIN:SE0007438577

Ratios

10-year key figure history for Toleranzia turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Toleranzia with index and moving average MA50 and MA200.

Stockprice:0,45
MA50:0,40
MA200:0,51
Price/MA200:-12,7 %
RSI (14):59,5
Price/MA50:11,7 %

Description

Toleranzia is a research company focused on the development of drug candidates for the treatment of autoimmune diseases. The company has developed a platform technology focused on the muscular disease myasthenia gravis. In addition, the technology has been used in other areas such as diabetes and multiple sclerosis. Research collaboration is done together with external partners within the field. The head office is based in Gothenburg.

Medical Equipment